IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

about

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

Item

http://www.wikidata.org/entity/Q58710862

description

scientific article published on 23 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@en

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@nl

type

Item

label

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@en

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@nl

prefLabel

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@en

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@nl

P1476

IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis

@en

P2093

Amanda J Saraf

http://www.w3.org/2001/XMLSchema#string

Amy C Gross

http://www.w3.org/2001/XMLSchema#string

Cheryl A London

http://www.w3.org/2001/XMLSchema#string

Doris A Phelps

http://www.w3.org/2001/XMLSchema#string

Hakan Cam

http://www.w3.org/2001/XMLSchema#string

Hemant K Bid

http://www.w3.org/2001/XMLSchema#string

John M Hinckley

http://www.w3.org/2001/XMLSchema#string

Laura Brandolini

http://www.w3.org/2001/XMLSchema#string

Maren Cam

http://www.w3.org/2001/XMLSchema#string

Michael A Arnold

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor self-seeding by circulating cancer cells

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

Tumor metastasis: molecular insights and evolving paradigms

Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Intra-tumour heterogeneity: a looking glass for cancer?

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

Genome-scale loss-of-function screening with a lentiviral RNAi library.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

P31

scholarly article

P356

10.1172/JCI.INSIGHT.99791

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ryan D Roberts

P577

2018-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30135299

http://www.w3.org/2001/XMLSchema#string

P932

6141177

http://www.w3.org/2001/XMLSchema#string